Overview
U.S. supplements maker's Q1 revenue rose 9% yr/yr to $122.9 mln
Adjusted EBITDA grew 33% to $14.6 mln, driven by higher sales
Gross margin improved to 73.2% from 72.1% on cost savings and market mix
Outlook
Company expects 2026 net sales between $500 mln and $515 mln
Company sees 2026 adjusted EBITDA between $50 mln and $54 mln
Result Drivers
REGIONAL SALES GROWTH - Co said sales grew across all regions, led by North America with 9% constant currency growth
DIGITAL CHANNEL EXPANSION - Co said its digital channel continues to scale, with strong engagement from new and returning consumers
GROSS MARGIN IMPROVEMENT - Co attributed higher gross margin to cost savings initiatives, market mix and favorable foreign exchange
Company press release: ID:nGNX960xc3
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Slight Beat*
$122.90 mln
$122.73 mln (2 Analysts)
Q1 Net Income
$5.10 mln
Q1 Adjusted EBITDA
Beat
$14.60 mln
$11.31 mln (2 Analysts)
Q1 Gross Margin
73.20%
Q1 Operating Income
$9.50 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy"
Wall Street's median 12-month price target for Nature's Sunshine Products Inc is $33.00, about 25.8% above its May 6 closing price of $26.24
The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 25 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)